Biblio
Export 1382 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is G [Clear All Filters]
“Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
, “Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.”, J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
, “Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.”, J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
, “APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke.”, J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
, “Can Subjective Memory Complaints Identify Aβ Positive and Aβ Negative Amnestic Mild Cognitive Impairment Patients?”, J Alzheimers Dis, vol. 70, no. 4, pp. 1103-1111, 2019.
, “Can Subjective Memory Complaints Identify Aβ Positive and Aβ Negative Amnestic Mild Cognitive Impairment Patients?”, J Alzheimers Dis, vol. 70, no. 4, pp. 1103-1111, 2019.
, “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
, “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
, “A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.”, J Alzheimers Dis, vol. 67, no. 1, pp. 181-195, 2019.
, “Evaluation of Medicare Claims Data as a Tool to Identify Dementia.”, J Alzheimers Dis, vol. 67, no. 2, pp. 769-778, 2019.
, “Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial.”, J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
, “Geographical Variation in the Diagnostic Rate and Quality of Dementia Diagnoses.”, J Alzheimers Dis, vol. 69, no. 2, pp. 513-520, 2019.
, “Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.”, J Alzheimers Dis, vol. 67, no. 2, pp. 481-488, 2019.
, “Head Position During Sleep: Potential Implications for Patients with Neurodegenerative Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 631-638, 2019.
, “Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life.”, J Alzheimers Dis, vol. 69, no. 3, pp. 817-827, 2019.
, “Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice.”, J Alzheimers Dis, vol. 68, no. 2, pp. 809-837, 2019.
, “Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 67, no. 2, pp. 639-651, 2019.
, “Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 67, no. 2, pp. 639-651, 2019.
, “Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.”, J Alzheimers Dis, vol. 69, no. 4, pp. 1077-1087, 2019.
, “Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model.”, J Alzheimers Dis, vol. 67, no. 2, pp. 503-513, 2019.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
,